Patients have come before Congress pleading for relief from unaffordable health care bills for years. In response, many ...

As the 2025 Louisiana legislative session came to a close Thursday, a closely watched bill that aimed to regulate pharmacy benefit managers, or PBMs, failed to make it through the Senate. But it may ...

Change management intentional design drives success in patient blood management programs by improving adoption and clinical outcomes in hospitals.

Pharmacy Benefit Managers (PBMs) have long operated as powerful middlemen in the U.S. drug supply chain, influencing which medicines patients can access and at what price. New federal reforms aim to ...

The executive order signed by President Trump April 15, takes a step toward addressing the opaque and anticompetitive practices of pharmacy benefit managers (PBMs). While this is an important ...

The U.S. House passed a federal funding bill that includes new restrictions on PBM compensation. PBM reform took a significant step forward this week as the U.S. House passed a federal funding bill ...

Once again, U.S. legislative reforms to rein in pharmacy benefit manager (PBM) business practices missed a ride to finally becoming law. This time, they were kicked out of the Trump administration’s ...

On February 3, 2026, Congress passed and the President signed the Consolidated Appropriations Act, 2026 (“CAA 26”), a legislative package that funds several federal agencies, including the Departments ...

Pharmacy benefit managers (PBMs) under the microscope for their role in high drug prices have often cited their reportedly slim profit margins as evidence that they do not drive up costs. The three ...

On Jan. 21, the Missouri Senate held hearings in Jefferson City on Senate Bill 984, sponsored by Sen. Jill Carter, and Senate Bill 968, sponsored by Sen. Travis Fitzwater — important legislation aimed ...